Version 5.4
Mus musculus Gene: Leap2
Summary
InnateDB Gene IDBG-171608.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Leap2
Gene Name liver-expressed antimicrobial peptide 2
Synonyms
Species Mus musculus
Ensembl Gene ENSMUSG00000036216
Encoded Proteins
IDBP-171610
liver-expressed antimicrobial peptide 2
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000164406:
LEAP2 is a cysteine-rich cationic antimicrobial peptide (Krause et al., 2003 [PubMed 12493837]).[supplied by OMIM, Mar 2008]
Gene Information
Type Protein coding
Genomic Location Chromosome 11:53422181-53423170
Strand Reverse strand
Band B1.3
Transcripts
ENSMUST00000036045 ENSMUSP00000044166
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
Biological Process
GO:0042742 defense response to bacterium
Cellular Component
GO:0005576 extracellular region
Orthologs
Species
Homo sapiens
Bos taurus
Gene ID
Gene Order
ENSG00000164406
View Gene Order
ENSBTAG00000018926
Not yet available
Cross-References
SwissProt Q91V13
TrEMBL
UniProt Splice Variant
Entrez Gene 259301
UniGene Mm.24283
RefSeq NM_153069
OMIM
CCDS CCDS36150
HPRD
IMGT
MGI ID MGI:2672795
MGI Symbol Leap2
EMBL AJ409055 AJ409063 BC089593
GenPept AAH89593 CAC51472 CAC51519
RNA Seq Atlas 259301

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca